Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 2/20 | 0.30 |
| ▸ | HTR7 | P34969 | 2/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2693261 | 0.91 | CYP1A2 (0.36) | NPSR1CYP1A2CYP2A6PSMB5FFAR4 | |
| SCHEMBL13627016 | 0.89 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL13325298 | 0.87 | MAPT (0.31) | MAPTL3MBTL1 | |
| SCHEMBL13627014 | 0.85 | NPSR1 (0.33) | NPSR1 | |
| SCHEMBL13593516 | 0.82 | MAPT (0.30) | MAPTL3MBTL1 | |
| SCHEMBL14264168 | 0.80 | ALDH1A1 (0.35) | NPSR1CYP1A2CYP2A6FFAR4TSHR | |
| SCHEMBL13627027 | 0.78 | NPC1 (0.32) | MAPTLMNATSHR | |
| SCHEMBL3418221 | 0.77 | CYP1A2 (0.38) | NPSR1CYP1A2CYP2A6PSMB5FFAR4 | |
| SCHEMBL2777218 | 0.75 | SCN4A (0.38) | CYP1A2CYP2A6L3MBTL1KMT2ASLC6A4 | |
| SCHEMBL7884180 | 0.74 | ALDH1A1 (0.38) | CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| US-7709675-B2 | Continuous method for the production of linear pentene nitriles | BASF SE (DE) | 2010-05-04 | — | — | US | disclosed |
| US-7709675-B2 | Continuous method for the production of linear pentene nitriles | BASF SE (DE) | 2010-05-04 | — | — | US | disclosed |
| US-20080242886-A1 | Continuous Method for the Production of Linear Pentene Nitriles | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| US-20080242886-A1 | Continuous Method for the Production of Linear Pentene Nitriles | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242886-A1 | Continuous Method for the Production of Linear Pentene Nitriles | CYC1, HVCN1, HMOX1 | NPSR1 1909/4885CYP1A2 146/4885CYP2A6 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.